Connect

School and Program Updates

School and Program Updates

UAB Names New Associate Dean for Research

Dr. Paul Muntner, professor of epidemiology at University of Alabama at Birmingham School of Public Health has been named the associate dean for research. In this role, he will facilitate research between the School of Public Health and the UAB Office of the Vice President for Research and Economic Development.

[Dr. Paul Muntner]

Dr. Muntner has extensive experience in research leadership positions. He is vice chair of the Statistics Committee for the American Heart Association, a member of the American College of Cardiology/American Heart Association Guideline for the Management of Hypertension, an associate editor for the Journal of the American Society of Hypertension and serves on the editorial boards of the American Journal of Kidney Diseases and American Journal of Cardiology.

“Paul has the credentials and relationships to move our research agenda forward and an excellent plan for building research capacity within the School of Public Health,” said Dr. Peter M. Ginter, interim dean of the School of Public Health. “In doing so, Paul will be a catalyst, role model and guiding force as he facilitates the school’s research initiatives.”

Dr. Muntner’s most recent research examines the burden of cardiovascular disease. He was the lead author on a recent national study that looked at the impact of the new American College of Cardiology and American Heart Association hypertension guideline. The study found that under the new guideline, approximately 103.3 million people in the United States will be categorized as having high blood pressure.

In his new role, he will be responsible for setting up an effective office of research in the School of Public Health, communicating with the faculty to learn more about their current work and facilitating research and associated intramural funding applications.

Dr. Muntner is also the director of the Lister Hill Center for Health Policy, the director of the Hypertension Center, and and the co-director of the Pharmacoepidemiology and Economics Research Unit.